Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy.

By Warwick B. Dunn, David Broadhurst, H. Atherton, Royston Goodacre, Julian L. Griffin. Chemical Society Reviews, 2011

789 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Molecular Biology, Spectroscopy

View Paper: https://www.semanticscholar.org/paper/e9ca8ef090609d1506b442d707f63d63a8b1c868

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

In Spectroscopy

Citations in the corpus

Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry (2011, methodology): “Controlled experiments including case-control studies can be performed before large-scale studies of the general population are performed (see ref”
Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. (2015, background): “ties with a mass difference and thereby naturally leads to rich and complicated spectroscopic data.(7,47,51,52) However, analysis”
A tutorial review: Metabolomics and partial least squares-discriminant analysis--a marriage of convenience or a shotgun wedding. (2015, background): “However, due to the complexity of the metabolome one method does not fit all [21] and covering this wide-range of metabolites requires the use of multiple protocols and analytical instruments [47–49].”
The role of reporting standards for metabolite annotation and identification in metabolomic studies (2013, background): “Metabolomics studies focus on the investigation of the complex and dynamic biochemical interactions of metabolites, both with other biochemicals and their environment [1].”
Targeted Metabolomics (2012, background): “…including neuroscience (Han, 2002; Griffin et al., 2004), cancer biology (Griffiths et al., 2002; Odunsi et al., 2005), microbiology (Oursel et al., 2007), cellular lipid signaling (Wakelam et al., 2007), and metabolic syndrome (Wang et al., 2005; Festa et al., 2005; Roberts et al., 2011).”